The headlines are harsh. "Terrible," devastating," and "crippling," are words the biomedical industry is using to describe President Trump’s proposed cuts to science and medical research in his 2018 budget. Public health interests do, however, see some new resources. While only Congress has the authority to make budget and appropriation decisions, the administration’s budget is considered a "blueprint" of the president’s spending priorities. Experts say based on the deep cuts in the 2018 budget proposal to the U.S. Department of Health and Human Services (HHS), including the National Institutes of Health (NIH), biomedical funding is clearly not a priority for President Trump. "The Trump administration’s proposed budget would cripple the science and technology enterprise through short-sighted cuts to discovery science programs and critical mission agencies alike," said Rush Holt, CEO of the American Association for the Advancement of Science in a statement. "Investments in federal research and development make significant contributions to economic growth and public well-being. The administration’s proposed cuts would threaten our nation’s ability to advance cures for disease, maintain our technological leadership, ensure a more prosperous energy future, and train the next generation of scientists and innovators." In his introductory message to the budget proposal President Trump […]